Skip to content

iRadimed IRMD Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

ICU Medical logo
ICU MedicalICUI
$1.28B+1.9%
ITG
Integer HoldingsITGR
$1.3B+1.7%
UFP Technologies logo
UFP TechnologiesUFPT
$170.71M
Limbach Holdings, Inc. logo
Limbach Holdings, Inc.LMB
$59.13M+37.7%
Mirion Technologies logo
Mirion TechnologiesMIR
$1.06B+35.1%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's finite lived intangible assets - gross?
iRadimed (IRMD) reported finite lived intangible assets - gross of $5.01M in Q1 2026.
What does finite lived intangible assets - gross mean?
This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.